Press Releases

Paris: Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A—alongside enhanced supply chain resilience as “The Good”. The ongoing uncertainty around the intentions and practical implications of...

London, UK: Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics. Jo brings a wealth of experience across clinical development, having spent her career addressing solutions that challenge processes and...

ST. LOUIS, Mo. and WOODBURY, Minn: (Business Wire) – Kindeva Drug Delivery’s global health security division, Meridian Medical Technologies, LLC, secured a contract valued at up to $129 million to supply DuoDote®, a chemical nerve agent antidote autoinjector, to the Strategic National Stockpile (SNS), managed by the Administration for Strategic Preparedness and Response (ASPR)...

Concept-to-commercialization services include precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display bio-based PVC compounds, antimicrobial compounding and reinforced paper for med device packaging. Wayne, PA – TekniPlex Healthcare, which utilizes advanced materials science expertise to...

hubXchange, the premier platform for senior-level knowledge exchange in life sciences, is excited to announce its upcoming series of specialized roundtable events taking place in San Diego on February 19th, 24th, and 25th, 2025. These exclusive, closed-door gatherings will...

Hyderabad: Aragen Life Sciences, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), has received the prestigious Platinum Medal rating from EcoVadis. This highest level of recognition places Aragen in the top 1% of companies worldwide for its...

Paris: New research released ahead of Pharmapack Europe – the continent’s largest partnering event for medical device and packaging innovation – has ranked the Basel region as the most attractive destination in Europe for launching a new drug device company. The study surveyed over 280 global pharmaceutical executives, asking them to identify...